# Sub-dissociative Dose Ketamine in Treatment of Vaso-occlusive Pain Event in Children and Young Adults

> **NCT07369024** · PHASE2 · RECRUITING · sponsor: **Mohsen Saidinejad** · enrollment: 120 (estimated)

## Conditions studied

- Sickle Cell Disease
- Vaso-Occlusive Pain Episode in Sickle Cell Disease
- Ketamine Infusion
- Pain Management
- Vaso-Occlusive Crises

## Interventions

- **DRUG:** Sub-dissociative Ketamine Infusion
- **DRUG:** Normal Saline Placebo Infusion

## Key facts

- **NCT ID:** NCT07369024
- **Lead sponsor:** Mohsen Saidinejad
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-04-01
- **Primary completion:** 2027-12-31
- **Final completion:** 2028-04-30
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2026-03-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07369024

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07369024, "Sub-dissociative Dose Ketamine in Treatment of Vaso-occlusive Pain Event in Children and Young Adults". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT07369024. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*